TCMD Stock Analysis: Buy, Sell, or Hold?
TCMD - Tactile Systems Technology, Inc.
$26.12
0.24 (0.93%)
▲
5d:
-2.76%
30d:
-10.82%
90d:
-10.76%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 04, 2026
Smart Money Accumulation
TCMD is down 12.6% this week, but smart money is accumulating calls. Top strike: $25 2026-04-17 with 26 OI. Call ratio: 94% View Scanner →
Strength: 10.0/10
Get Alerted When TCMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TCMD shows positive signals but monitor for confirmation. Market pricing in 12.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: TCMD shows positive signals but monitor for confirmation. Market pricing in 12.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.05
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$44.74
41.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TCMD is currently trading at $26.12, which is considered oversold relative to its 30-day fair value range of $26.64 to $29.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.5) compared to its historical average (26.1). Remarkably, the market is currently pricing in an annual earnings decline of 12.5% over the next few years. This pessimistic expectation contrasts with the company's recent 17.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, TCMD is in a uptrend. The price is currently testing key support at $25.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TCMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.00 (+46.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TCMD is in a uptrend. The price is currently testing key support at $25.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TCMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.00 (+46.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$26.64 -
$29.23
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.8% below Wall St target ($38.00)
Fair Price Analysis
30-Day Fair Range
$26.64 -
$29.23
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.81
(6.9%)
Support & Resistance Levels
Support Level
$25.59
Resistance Level
$27.99
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.49
Wall Street Target
$38.00
(+46.8%)
Revenue Growth (YoY)
21.0%
Earnings Growth (YoY)
17.6%
Profit Margin
5.8%
Valuation Discount vs History
-12.5% cheaper
PE vs Historical
17.5 vs 26.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.5%
(market-implied from PE analysis)
1-Year Target
$23.29
(-10%)
2-Year Target
$20.96
(-19%)
3-Year Target
$18.87
(-27%)
3-Yr Target (if PE normalizes)
(PE: 17→26)
$28.16
(+9%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 32.7%)
$77.36
(+199%)
Base:
(SPY PE: 17.5, Growth: 32.7%)
$60.52
(+134%)
Bear:
(PE: 14.9, Growth: 32.7%)
$51.45
(+99%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 31.83 | Current EPS (TTM): $0.82
Bull Case
$51.82
(+96%)
Analyst growth 80.5%, PE expands to 35.0
Base Case
$47.11
(+78%)
Market implied 80.5%, PE stable at 31.8
Bear Case
$17.75
(-33%)
Severe decline -20.0%, PE contracts to 27.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.5 to 26.1
Stabilization Target:
$38.63
(+49.3%)
PE Expansion Potential:
+49.3%
Share & Embed Analysis
Last updated: March 31, 2026 9:54 AM ET
Data refreshes hourly during market hours. Next update: 10:54 AM
Data refreshes hourly during market hours. Next update: 10:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Elaine M Birkemeyer
SELL
7701 shares
2026-02-24
Kristie Burns
SELL
6246 shares
2026-02-24
Sheri Louise Dodd
SELL
10993 shares
2026-02-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 48 HOLD |
Advanced TCMD Option Strategies
Professional options setups generated by AI based on today's TCMD price and gamma walls.
